Play Audio Clip Listen to audio clip.
Scientists at Moderna Therapeutics, Inc. have now confirmed that their SVA-19 vaccine used in our newest study is highly effective against the most recent Zika virus outbreak. Now that the vaccine’s protection wanes, the clinical vaccine team at Moderna’s Vaccine Center is in an excellent position to quickly develop future vaccines that retain its high efficacy and efficiency.
And now to update you on another pioneering research of Moderna’s where their partner Merck & Co., Inc., has not only confirmed that cancer immunotherapy with the Anti-PD-1 antibody, dupilumab, greatly improves survival in heavily pretreated patients with several forms of cancer, but also shows that PD-1 tumor cells are only selectively destroyed by this therapy, not by the system as a whole.
So we wish these scientists all the best for the future and you can show your support by visiting our website at modernathologies.com.